CSL Limited
Australian biotechnology company
📊 Rating
2 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Biotechnology (2)
- Corporate Finance (1)
- Market Analysis (1)
- Corporate Leadership (1)
- Business Management (1)
🏷️ Keywords
CSL Limited (2) · Earnings Call (1) · Net Profit (1) · CSL Behring (1) · CSL Vifor (1) · Plasma Collection (1) · H1 2026 (1) · Australian Stocks (1) · Gordon Naylor (1) · Interim CEO (1) · Biotech industry (1) · Melbourne (1) · Leadership transition (1) · Paul Perreault (1)
📖 Key Information
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
📰 Related News (2)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside CSL Limited:
- 🌐 Interim management (1 shared articles)
- 🌐 Melbourne (1 shared articles)
- 🏢 CSL Behring (1 shared articles)
- 🌐 Net income (1 shared articles)
- 🏢 Earnings call (1 shared articles)
- 🏢 CSL Vifor (1 shared articles)